Cargando…
In Response to “Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision Making: A New Way of Counting”
Autores principales: | Belderbos, Robert A., Aerts, Joachim G.J. V., von der Thüsen, Jan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486919/ https://www.ncbi.nlm.nih.gov/pubmed/34734195 http://dx.doi.org/10.1016/j.jtocrr.2021.100215 |
Ejemplares similares
-
Intratumor Distribution of Ki-67 Antigen Beyond Labeling Index for Clinical Decision-Making: A New Way of Counting
por: Bulloni, Matteo, et al.
Publicado: (2021) -
Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma
por: Belderbos, Robert A., et al.
Publicado: (2021) -
Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015) -
The cell proliferation antigen Ki-67 organises heterochromatin
por: Sobecki, Michal, et al.
Publicado: (2016) -
Clinical Significance of Ki-67 Labeling Index in Pituitary Macroadenoma
por: Paek, Kyung-Il, et al.
Publicado: (2005)